Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Dyslipidemia

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 33 articles: HTML format Text format

Single Articles

May 2018
1. KOEHLER VF, Parhofer KG
   Xanthoma Striatum Palmare.
   N Engl J Med. 2018;378:e26.
   PubMed     Text format    
   
   
   November 2017
2. CALABRO P, Gragnano F, Pirro M
   Cognitive Function in a Randomized Trial of Evolocumab.
   N Engl J Med. 2017;377:1996-7.
   PubMed     Text format    
   
   
   
3. GIUGLIANO RP, Sabatine MS, Ott BR
   Cognitive Function in a Randomized Trial of Evolocumab.
   N Engl J Med. 2017;377:1997.
   PubMed     Text format    
   
   
   September 2017
4. ADAMS TD, Davidson LE, Litwin SE, Kim J, et al
   Weight and Metabolic Outcomes 12 Years after Gastric Bypass.
   N Engl J Med. 2017;377:1143-1155.
   PubMed     Text format     Abstract available
   
   
   August 2017
5. POONIA A, Giridhara P
   Xanthomas in Familial Hypercholesterolemia.
   N Engl J Med. 2017;377:e7.
   PubMed     Text format    
   
   
   July 2017
6. GAUDET D, Gipe DA, Pordy R, Ahmad Z, et al
   ANGPTL3 Inhibition in Homozygous Familial Hypercholesterolemia.
   N Engl J Med. 2017;377:296-297.
   PubMed     Text format    
   
   
   April 2017
7. RIDKER PM, Tardif JC, Amarenco P, Duggan W, et al
   Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab.
   N Engl J Med. 2017;376:1517-1526.
   PubMed     Text format     Abstract available
   
   
   
8. BEIGNEUX AP, Miyashita K, Ploug M, Blom DJ, et al
   Autoantibodies against GPIHBP1 as a Cause of Hypertriglyceridemia.
   N Engl J Med. 2017 Apr 5. doi: 10.1056/NEJMoa1611930.
   PubMed     Text format     Abstract available
   
   
   March 2017
9. RAY KK, Landmesser U, Leiter LA, Kallend D, et al
   Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol.
   N Engl J Med. 2017 Mar 17. doi: 10.1056/NEJMoa1615758.
   PubMed     Text format     Abstract available
   
   
   
10. RIDKER PM, Revkin J, Amarenco P, Brunell R, et al
    Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.
    N Engl J Med. 2017 Mar 17. doi: 10.1056/NEJMoa1701488.
    PubMed     Text format     Abstract available
    
    
    
11. SABATINE MS, Giugliano RP, Keech AC, Honarpour N, et al
    Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.
    N Engl J Med. 2017 Mar 17. doi: 10.1056/NEJMoa1615664.
    PubMed     Text format     Abstract available
    
    
    February 2017
12. KHERA AV, Kathiresan S
    Child-Parent Familial Hypercholesterolemia Screening in Primary Care.
    N Engl J Med. 2017;376:498-9.
    PubMed     Text format    
    
    
    
13. MARTIN AC, Watts GF
    Child-Parent Familial Hypercholesterolemia Screening in Primary Care.
    N Engl J Med. 2017;376:498.
    PubMed     Text format    
    
    
    
14. KULLO IJ, Safarova MS
    Child-Parent Familial Hypercholesterolemia Screening in Primary Care.
    N Engl J Med. 2017;376:498.
    PubMed     Text format    
    
    
    
15. HINGORANI AD, Futema M, Humphries S
    Child-Parent Familial Hypercholesterolemia Screening in Primary Care.
    N Engl J Med. 2017;376:499.
    PubMed     Text format    
    
    
    
16. 
    Child-Parent Familial Hypercholesterolemia Screening in Primary Care.
    N Engl J Med. 2017;376:498-500.
    PubMed     Text format    
    
    
    January 2017
17. SCHULMAN AR, Vaidya A, Tavakkoli A, Jajoo K, et al
    Making the Connection.
    N Engl J Med. 2017;376:e5.
    PubMed     Text format    
    
    
    October 2016
18. WALD DS, Bestwick JP, Morris JK, Whyte K, et al
    Child-Parent Familial Hypercholesterolemia Screening in Primary Care.
    N Engl J Med. 2016;375:1628-1637.
    PubMed     Text format     Abstract available
    
    
    
19. MCCRINDLE BW, Gidding SS
    What Should Be the Screening Strategy for Familial Hypercholesterolemia?
    N Engl J Med. 2016;375:1685-1686.
    PubMed     Text format    
    
    
    September 2016
20. LAMPSON BL, Gray SW, Cibas ES, Levy BD, et al
    CLINICAL PROBLEM-SOLVING. Tip of the Tongue.
    N Engl J Med. 2016;375:880-6.
    PubMed     Text format    
    
    
    May 2016
21. CUSHMAN WC, Goff DC Jr
    More HOPE for Prevention with Statins.
    N Engl J Med. 2016;374:2085-7.
    PubMed     Text format    
    
    
    April 2016
22. YUSUF S, Bosch J, Dagenais G, Zhu J, et al
    Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available
    
    
    March 2016
23. KERSTEN S
    The Genetics of Dyslipidemia--When Less Is More.
    N Engl J Med. 2016;374:1192-3.
    PubMed     Text format    
    
    
    January 2016
24. INGE TH, Courcoulas AP, Jenkins TM, Michalsky MP, et al
    Weight Loss and Health Status 3 Years after Bariatric Surgery in Adolescents.
    N Engl J Med. 2016;374:113-23.
    PubMed     Text format     Abstract available
    
    
    October 2015
25. EVERETT BM, Smith RJ, Hiatt WR
    Reducing LDL with PCSK9 Inhibitors--The Clinical Benefit of Lipid Drugs.
    N Engl J Med. 2015;373:1588-91.
    PubMed     Text format    
    
    
    
26. SCHULMAN KA, Balu S, Reed SD
    Specialty Pharmaceuticals for Hyperlipidemia - Impact on Insurance Premiums.
    N Engl J Med. 2015.
    PubMed     Text format     Abstract available
    
    
    September 2015
27. BURTON BK, Balwani M, Feillet F, Baric I, et al
    A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency.
    N Engl J Med. 2015;373:1010-20.
    PubMed     Text format     Abstract available
    
    
    August 2015
28. SABATINE MS, Wasserman SM, Stein EA
    PCSK9 Inhibitors and Cardiovascular Events.
    N Engl J Med. 2015;373:774-5.
    PubMed     Text format    
    
    
    
29. GOEMANN IM, Londero TM, Dora JM
    PCSK9 Inhibitors and Cardiovascular Events.
    N Engl J Med. 2015;373:773-4.
    PubMed     Text format    
    
    
    
30. AUER J, Berent R, Primus C
    PCSK9 Inhibitors and Cardiovascular Events.
    N Engl J Med. 2015;373:773.
    PubMed     Text format    
    
    
    
31. ROBINSON JG, Kastelein JJ
    PCSK9 Inhibitors and Cardiovascular Events.
    N Engl J Med. 2015;373:774.
    PubMed     Text format    
    
    
    July 2015
32. GAUDET D, Alexander VJ, Baker BF, Brisson D, et al
    Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia.
    N Engl J Med. 2015;373:438-47.
    PubMed     Text format     Abstract available
    
    
    
33. PI-SUNYER X, Astrup A, Fujioka K, Greenway F, et al
    A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management.
    N Engl J Med. 2015;373:11-22.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dyslipidemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: